What is Pyruvate Kinase Deficiency

Pyruvate Kinase Deficiency is a rare, inherited metabolic disorder that causes red blood cells to break down prematurely, leading to chronic hemolytic anemia. By preventing the red blood cells from producing enough energy, Pyruvate Kinase Deficiency significantly impacts the body's ability to transport oxygen effectively.

What exactly is Pyruvate Kinase Deficiency?

Pyruvate Kinase Deficiency is a genetic condition that affects the glycolytic pathway in red blood cells. Because red blood cells lack mitochondria, they rely entirely on the enzyme pyruvate kinase to produce energy (ATP). When this enzyme is missing or dysfunctional, the cells become rigid and are destroyed by the spleen, resulting in the hallmark symptom of chronic hemolytic anemia.

How does Pyruvate Kinase Deficiency affect the body?

The primary impact of Pyruvate Kinase Deficiency is on the circulatory system, but it can lead to secondary complications throughout the body. Common manifestations include:

• Chronic hemolysis: The ongoing destruction of red blood cells.


• Jaundice: Yellowing of the skin and eyes due to high bilirubin levels.


• Splenomegaly: An enlarged spleen caused by the increased workload of filtering damaged red blood cells.


• Iron overload: Even in patients who do not receive regular blood transfusions, iron levels can become dangerously high.


• Gallstones: A common side effect of chronic red blood cell breakdown.

How common is Pyruvate Kinase Deficiency?

Pyruvate Kinase Deficiency is considered an ultra-rare disease. While exact global prevalence is difficult to determine, it is estimated to affect approximately 1 in 20,000 people in the Caucasian population. Because the condition is often underdiagnosed or misdiagnosed as other forms of hemolytic anemia, the true incidence may be higher. It affects both males and females equally and can be found in all ethnic groups, though specific mutations may be more prevalent in certain geographic populations.

Is Pyruvate Kinase Deficiency hereditary?

Yes, Pyruvate Kinase Deficiency is an autosomal recessive disorder. This means that a child must inherit two copies of the mutated PKLR gene—one from each parent—to manifest the disease. Parents who are carriers of a single mutation typically do not show symptoms of the condition.

Next steps

• Consult with a hematologist who specializes in rare red cell disorders.


• Request genetic testing to confirm the specific PKLR gene mutations.


• Join the community at DiseaseMaps.org to connect with others sharing their experience with Pyruvate Kinase Deficiency.


• Monitor iron levels regularly, even if you are not currently transfusion-dependent.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• Orphanet: Pyruvate kinase deficiency (ORPHA:773)


• NIH Genetic and Rare Diseases Information Center (GARD): Pyruvate kinase deficiency


• OMIM: Pyruvate Kinase Deficiency of Erythrocyte (Entry #266200)


• Pyruvate Kinase Deficiency Foundation (pkdeficiency.com)